Monday, May 2, 2011

Propolis Bioflavonoid Shows Anti-Cancer Activity

Effect of Propolis and Caffeic Acid Phenethyl Ester (CAPE) on NFκB Activation by HTLV-1 Tax
Antiviral Research, Article in Press



HTLV-1 is the etiological agent of an aggressive malignancy of the CD4+ T-cells, adult T-cell leukemia (ATL) and other sever clinical disorders. The viral Tax protein is a key factor in HTLV-1 pathogenicity. A major part of Tax oncogenic potential is accounted for by its capacity of inducing the transcriptional activity of the NFκB factors, which regulate the expression of numerous cellular genes. 

Propolis (PE), a natural product produced by honeybees, has been used for long time in folk medicine. One of PE active components, caffeic acid phenylethyl ester (CAPE), was well characterized and found to be a potent inhibitor of NFκB activation. Therefore, the aim of this study was to pursue the possibility of blocking Tax oncogenic effects by treatment with these natural products. 

Human T-cell lines were used in this study since these cells are the main targets of HTLV-1 infections. We tried to determine which step of Tax-induced NFκB activation is blocked by these products. 

Our results showed that both tested products substantially inhibited activation of NFκB-dependent promoter by Tax. However, only PE could efficiently inhibit also the Tax-induced activation of SRF- and CREB- dependent promoters. 

Our results showed also that PE and CAPE strongly prevented both Tax binding to IκBα and its induced degradation by Tax. However, both products did not interfere in the nuclear transport of Tax or NFκB proteins.

1 comment:

  1. Columbia University discovered the anti-tumor properties in propolis, namely caffeic acid phenethyl ester (CAPE) in 1988. Why is it that these studies can't move ahead with such positive results?

    ReplyDelete